Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906158 | 0.90 | MAPK1 (0.42) | TSHRALDH1A1TDP1MAPK1CYP1A2 | |
| SCHEMBL11656996 | 0.83 | MAPK1 (0.37) | TSHRTDP1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL29884 | 0.83 | MAPK1 (0.42) | TSHRTDP1MAPK1CYP1A2CYP3A4 | |
| SCHEMBL6348129 | 0.82 | MAPK1 (0.33) | TSHRMAPK1HSD17B10 | |
| SCHEMBL6348131 | 0.79 | MAPK1 (0.34) | MAPK1CYP1A2CYP3A4CYP2C9HIF1A | |
| SCHEMBL5354530 | 0.79 | MAPK1 (0.34) | MAPK1CYP1A2CYP3A4CYP2C9HIF1A | |
| SCHEMBL11659759 | 0.77 | MAPK1 (0.33) | TSHRALDH1A1MAPK1 | |
| SCHEMBL7757431 | 0.77 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL5354533 | 0.77 | MAPT (0.33) | MAPK1 | |
| SCHEMBL2027418 | 0.76 | TSHR (0.36) | TSHRALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353938-A1 | DYNAMICALLY CROSSLINKED POLYOLEFIN PRODUCED THROUGH A POST-REACTOR PROCESS WITH A DYNAMIC DISULFIDE CROSSLINKER | BRASKEM AMERICA INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250346695-A1 | ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL | BRASKEM AMERICA INC (US) | 2025-11-13 | — | — | US | claimed |
| WO-2025235568-A1 | ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL | BRASKEM AMERICA, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250243302-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-07-31 | — | — | US | claimed |
| WO-2025129179-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-06-19 | — | — | WO | claimed |
| EP-4486823-A1 | OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME | Braskem S.A. (BR) | 2025-01-08 | — | — | EP | claimed |
| CN-118974149-A | Open cell polymer foam composition with adjustable tortuosity and preparation method thereof | 布拉斯科有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2023161726-A1 | OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME | BRASKEM S.A. (BR) | 2023-08-31 | — | — | WO | claimed |
| CN-107438507-B | Electronic device module | YPAREX有限公司 | 2021-03-02 | — | — | CN | claimed |
| EP-3248224-B1 | ELECTRONIC DEVICE MODULE | YPAREX B V (NL) | 2020-12-23 | — | — | EP | claimed |
| US-20170373209-A1 | ELECTRONIC DEVICE MODULE | YPAREX B.V. (NL) | 2017-12-28 | — | — | US | claimed |
| US-6599990-B2 | Molecular weight modification of polypropylene by 4-(t-amylperoxy)-4-methyl-2-pentanol and polypropylene so modified suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices is disclosed. | ATOFINA CHEMICALS, INC. | 2003-07-29 | — | — | US | claimed |
| US-20030119997-A1 | Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification | ARKEMA INC. | 2003-06-26 | — | — | US | claimed |
| US-6503990-B2 | Decreasing molecular weight of polypropylene with 4-(t-amylperoxy)-4-methyl-2-pentanol; product suitable for handling and packaging food, beverages and pharmaceuticals and for use in medical devices | ATOFINA CHEMICALS, INC. | 2003-01-07 | — | — | US | claimed |
| US-20020137883-A1 | Safe, efficient, low t-butanol forming organic peroxide for polypropylene modification | ARKEMA INC. | 2002-09-26 | — | — | US | claimed |
| EP-1223178-A1 | Polypropylene modification using organic peroxide | Atofina Chemicals, Inc. (US) | 2002-07-17 | — | — | EP | claimed |
| US-20260125531-A1 | Silane Crosslinked Ethylene/a-Olefin Block Copolymer Bead Foam | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-12612501-B2 | Silane crosslinked ethylene/α-olefin block copolymer bead foam | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-28 | — | — | US | disclosed |
| EP-0667339-A1 | Novel unsaturated peroxides, polymeric derived therefrom and their uses | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-08-16 | — | — | EP | disclosed |
| US-5051531-A | As polymerization catalysts and for crosslinking | ATOCHEM NORTH AMERICA, INC. (US) | 1991-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125531-A1 | Silane Crosslinked Ethylene/a-Olefin Block Copolymer Bead Foam | SUCLG1, OLA1, BOLA2; BOLA2B | TSHR 3944/4885ALDH1A1 2800/4885TDP1 4344/4885 |
| US-12612501-B2 | Silane crosslinked ethylene/α-olefin block copolymer bead foam | EEF1G, SUCLG1, OLA1 | TSHR 4022/4885ALDH1A1 2966/4885TDP1 4444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.